NEW YORK (GenomeWeb) – Spanish molecular diagnostics firm Stat-Dx today said that it has secured a €20 million ($22.4 million) loan facility from the European Investment Bank for the development of diagnostic tools to identify infectious pathogens.

The loan will be drawn in two tranches over a three-year period with full repayment on the maturity date five years ahead. The funds will go toward the cofinancing of a three-year project "aimed at enabling faster and more accurate diagnostics that will replace current complex protocols to obtain analytical results," Stat-Dx said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.